Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Association between oestrogens receptor expressions in breast cancer and comorbidities: a cross-sectional, population-based study.

de Decker L, Campone M, Retornaz F, Berrut G, Kabeshova A, Molinié F, Beauchet O.

PLoS One. 2014 May 21;9(5):e98127. doi: 10.1371/journal.pone.0098127. eCollection 2014.

PMID:
24848085
[PubMed - in process]
Free PMC Article
2.

Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women.

Vogel VG.

Breast Cancer (Dove Med Press). 2011 Oct 20;3:127-37. doi: 10.2147/BCTT.S11288. Review.

PMID:
24367182
[PubMed]
Free PMC Article
3.

Validation of a breast cancer risk prediction model developed for Black women.

Boggs DA, Rosenberg L, Pencina MJ, Adams-Campbell LL, Palmer JR.

J Natl Cancer Inst. 2013 Mar 6;105(5):361-7. doi: 10.1093/jnci/djt008. Epub 2013 Feb 14.

PMID:
23411594
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study.

Pastor-Barriuso R, Ascunce N, Ederra M, Erdozáin N, Murillo A, Alés-Martínez JE, Pollán M.

Breast Cancer Res Treat. 2013 Feb;138(1):249-59. doi: 10.1007/s10549-013-2428-y. Epub 2013 Feb 3.

PMID:
23378108
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Consumption of dairy and meat in relation to breast cancer risk in the Black Women's Health Study.

Genkinger JM, Makambi KH, Palmer JR, Rosenberg L, Adams-Campbell LL.

Cancer Causes Control. 2013 Apr;24(4):675-84. doi: 10.1007/s10552-013-0146-8. Epub 2013 Jan 18.

PMID:
23329367
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study).

Gao F, Machin D, Chow KY, Sim YF, Duffy SW, Matchar DB, Goh CH, Chia KS.

BMC Cancer. 2012 Nov 19;12:529. doi: 10.1186/1471-2407-12-529.

PMID:
23164155
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR).

Cecchini RS, Costantino JP, Cauley JA, Cronin WM, Wickerham DL, Bandos H, Weissfeld JL, Wolmark N.

Cancer Prev Res (Phila). 2012 Nov;5(11):1321-9. doi: 10.1158/1940-6207.CAPR-12-0273. Epub 2012 Oct 11.

PMID:
23060039
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Evaluating breast cancer risk projections for Hispanic women.

Banegas MP, Gail MH, LaCroix A, Thompson B, Martinez ME, Wactawski-Wende J, John EM, Hubbell FA, Yasmeen S, Katki HA.

Breast Cancer Res Treat. 2012 Feb;132(1):347-53. doi: 10.1007/s10549-011-1900-9. Epub 2011 Dec 7.

PMID:
22147080
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women's health initiative clinical trials.

Crandall CJ, Aragaki AK, Cauley JA, McTiernan A, Manson JE, Anderson G, Chlebowski RT.

Breast Cancer Res Treat. 2012 Feb;132(1):275-85. doi: 10.1007/s10549-011-1848-9. Epub 2011 Nov 1.

PMID:
22042371
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Tamoxifen downregulates ets oncogene family members ETV4 and ETV5 in benign breast tissue: implications for durable risk reduction.

Euhus D, Bu D, Xie XJ, Sarode V, Ashfaq R, Hunt K, Xia W, O'Shaughnessy J, Grant M, Arun B, Dooley W, Miller A, Flockhart D, Lewis C.

Cancer Prev Res (Phila). 2011 Nov;4(11):1852-62. doi: 10.1158/1940-6207.CAPR-11-0186. Epub 2011 Jul 21.

PMID:
21778330
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Risk factor modification and projections of absolute breast cancer risk.

Petracci E, Decarli A, Schairer C, Pfeiffer RM, Pee D, Masala G, Palli D, Gail MH.

J Natl Cancer Inst. 2011 Jul 6;103(13):1037-48. doi: 10.1093/jnci/djr172. Epub 2011 Jun 24.

PMID:
21705679
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.

Farhat GN, Cummings SR, Chlebowski RT, Parimi N, Cauley JA, Rohan TE, Huang AJ, Vitolins M, Hubbell FA, Manson JE, Cochrane BB, Lane DS, Lee JS.

J Natl Cancer Inst. 2011 Apr 6;103(7):562-70. doi: 10.1093/jnci/djr031. Epub 2011 Feb 17.

PMID:
21330633
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.

Mealiffe ME, Stokowski RP, Rhees BK, Prentice RL, Pettinger M, Hinds DA.

J Natl Cancer Inst. 2010 Nov 3;102(21):1618-27. doi: 10.1093/jnci/djq388. Epub 2010 Oct 18.

PMID:
20956782
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivors.

Yen TW, Czypinski LK, Sparapani RA, Guo C, Laud PW, Pezzin LE, Nattinger AB.

Cancer. 2011 Jan 15;117(2):398-405. doi: 10.1002/cncr.25412. Epub 2010 Sep 7.

PMID:
20824718
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort.

Ma H, Henderson KD, Sullivan-Halley J, Duan L, Marshall SF, Ursin G, Horn-Ross PL, Largent J, Deapen DM, Lacey JV Jr, Bernstein L.

Breast Cancer Res. 2010;12(3):R35. doi: 10.1186/bcr2589. Epub 2010 Jun 18.

PMID:
20565829
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women.

Zheng W, Wen W, Gao YT, Shyr Y, Zheng Y, Long J, Li G, Li C, Gu K, Cai Q, Shu XO, Lu W.

J Natl Cancer Inst. 2010 Jul 7;102(13):972-81. doi: 10.1093/jnci/djq170. Epub 2010 May 18.

PMID:
20484103
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Effect of changing breast cancer incidence rates on the calibration of the Gail model.

Schonfeld SJ, Pee D, Greenlee RT, Hartge P, Lacey JV Jr, Park Y, Schatzkin A, Visvanathan K, Pfeiffer RM.

J Clin Oncol. 2010 May 10;28(14):2411-7. doi: 10.1200/JCO.2009.25.2767. Epub 2010 Apr 5.

PMID:
20368565
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk.

Crandall CJ, Aragaki AK, Chlebowski RT, McTiernan A, Anderson G, Hendrix SL, Cochrane BB, Kuller LH, Cauley JA.

Arch Intern Med. 2009 Oct 12;169(18):1684-91. doi: 10.1001/archinternmed.2009.303.

PMID:
19822825
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, Collyar D, Morrow M, Runowicz C, Pritchard KI, Hagerty K, Arun B, Garber J, Vogel VG, Wade JL, Brown P, Cuzick J, Kramer BS, Lippman SM; American Society of Clinical Oncology.

J Clin Oncol. 2009 Jul 1;27(19):3235-58. doi: 10.1200/JCO.2008.20.5179. Epub 2009 May 26.

PMID:
19470930
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk.

Cummings SR, Tice JA, Bauer S, Browner WS, Cuzick J, Ziv E, Vogel V, Shepherd J, Vachon C, Smith-Bindman R, Kerlikowske K.

J Natl Cancer Inst. 2009 Mar 18;101(6):384-98. doi: 10.1093/jnci/djp018. Epub 2009 Mar 10. Review.

PMID:
19276457
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk